Holen Sie sich die Stockscreener-App
12.02
2.12%
-0.26
Schlusskurs vom Vortag:
$12.28
Offen:
$12.3
24-Stunden-Volumen:
9.31M
Relative Volume:
0.90
Marktkapitalisierung:
$8.77B
Einnahmen:
$6.82B
Nettoeinkommen (Verlust:
$309.60M
KGV:
26.71
EPS:
0.45
Netto-Cashflow:
$747.20M
1W Leistung:
-6.60%
1M Leistung:
-24.35%
6M Leistung:
-46.79%
1J Leistung:
-51.47%
1-Tages-Spanne:
$12.02
$12.39
1-Wochen-Bereich:
$11.82
$12.88
52-Wochen-Spanne:
$11.82
$28.00
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Vergleichen Sie AVTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
12.02 | 8.77B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor CEO Michael Stubblefield to Speak at 2025 Bank of America Health Care Conference - MSN
Biopreservation Industry Worth $7.1 billion by 2029, with a CAGR of 9.8% - The Globe and Mail
Is Avantor, Inc. (AVTR) One of the Best Falling Stocks to Buy According to Analysts? - Insider Monkey
Avantor's (NYSE:AVTR) Profits Appear To Have Quality Issues - Yahoo Finance
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference - BioSpace
Avantor® to Participate in Bank of America Securities 2025 Healt - GuruFocus
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference – Company Announcement - Financial Times
Avantor in Radnor Is Losing Longtime CEO Michael Stubblefield - DELCO.Today
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y - MSN
Avantor, Inc. (AVTR): Among the Oversold Global Stocks to Buy According to Hedge Funds - Insider Monkey
Avantor Reports Q1 2025 Results, Expands Cost Transformation Goals - MSN
Avantor director, president and CEO to step down - Pennsylvania Business Report -
Goldman Sachs cuts Avantor stock rating, slashes price target By Investing.com - Investing.com India
Avantor Executives Increase Their Holdings - TradingView
Goldman Sachs cuts Avantor stock rating, slashes price target - Investing.com Australia
Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...' - Benzinga
Why Avantor, Inc. (AVTR) Crashed on Monday - MSN
Demystifying Avantor: Insights From 16 Analyst Reviews - Nasdaq
Goldman Sachs Downgrades Avantor to Neutral From Buy, Adjusts Price Target to $14 From $23 - marketscreener.com
Goldman Sachs Downgrades Avantor (AVTR) with Revised Price Targe - GuruFocus
Goldman Sachs Downgrades Avantor (AVTR) with Revised Price Target | AVTR Stock News - GuruFocus
Morgan Stanley cuts Avantor stock rating, slashes price target By Investing.com - Investing.com Canada
Avantor stock rating cut to Hold at TD Cowen, target drops to $15.50 - Investing.com Canada
Avantor CEO Michael Stubblefield to Step Down, Search for Successor Underway - MyChesCo
Avantor (AVTR) Target Price Cut by Raymond James as Challenges P - GuruFocus
Barclays Reaffirms Their Buy Rating on Avantor (AVTR) - The Globe and Mail
Avantor (AVTR) Stock: Q125 Revenue Miss Deepens Concerns - CoinCentral
RBC Capital cuts Avantor price target to $20, maintains Outperform By Investing.com - Investing.com India
Avantor, Inc. (NYSE:AVTR) Q1 2025 Earnings Call Transcript - MSN
Avantor and NuSil Agree to Merge - CHEManager
Avantor’s Stock Faces Downgrades Amid Revenue Slump and Leadership Changes - sigortahaber.com
Morgan Stanley cuts Avantor stock rating, slashes price target - Investing.com
RBC Capital cuts Avantor price target to $20, maintains Outperform - Investing.com Australia
Bernstein cuts Avantor stock price target to $15 from $18 By Investing.com - Investing.com India
Stifel cuts Avantor stock rating to hold, slashes target to $14 By Investing.com - Investing.com Nigeria
Bernstein cuts Avantor stock price target to $15 from $18 - Investing.com
Analysts downgrade Avantor on earnings miss, CEO transition and tariff risks - Investing.com India
Avantor’s Hold Rating: Challenges in Bioprocess and Lab Consumables Amid Low Valuation - TipRanks
Avantor: Overcoming Challenges with Strategic Leadership and Attractive Valuation - TipRanks
Avantor Analysts Cut Their Forecasts After Q1 Results - Benzinga
This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday - Benzinga
Stifel cuts Avantor stock rating to hold, slashes target to $14 - Investing.com
Stifel Downgrades Avantor to Hold From Buy, Adjusts Price Target to $14 From $26 - marketscreener.com
Barclays Adjusts Price Target for Avantor (AVTR) Following Q1 Re - GuruFocus
Avantor (AVTR) Downgraded by TD Cowen Amid Revised Outlook | AVT - GuruFocus
Avantor (AVTR) Downgraded by Morgan Stanley Amid Uncertainty | A - GuruFocus
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.40%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):